Search Results for: GENE CELL THERAPY Its Growing
Articles
Catalent Increases Specialized Packaging Capabilities at its Philadelphia Facility to Support Growing Biologic & Cell & Gene Therapy Markets January 11, 2022
Catalent recently announced it has increased cold chain packaging capabilities at its Philadelphia facility to support increased demand for the...GENE & CELL THERAPY - Its Growing Potential to Disrupt Drug Research & Healthcare Delivery October 2, 2017
Jeff Galvin believes as the pace of gene and cell therapies accelerates over this next decade, potential cures for chronic diseases, cancer cures, and autosomal defect cures will result, and the efficacy of new therapeutics may move as much as $500 billion from traditional pharmaceuticals to gene technologies.
Kincell Bio & Imugene Announce Strategic Manufacturing & Process Development Partnership April 16, 2024
Kincell Bio to acquire Imugene’s North Carolina manufacturing facility for up to $6M USD in upfront and milestone-driven payments over 3 years….
PolTREG Identifies Promising Efficacy Biomarker for Type-1 Diabetes in Patients Treated With its Treg Therapy in Combination With Rituximab April 4, 2024
PolTREG S.A. recemtly announced it has published data in International Immunopharmacology, which suggest that PD-1+ T-cells are a dependable biomarker...Bio-Rad Launches Vericheck ddPCR Replication Competent Lentivirus & Replication Competent AAV Kits for Cell & Gene Therapy Production February 27, 2024
Bio-Rad Laboratories, Inc. recently announced the launch of the Vericheck ddPCR Replication Competent Lentivirus Kit and the Vericheck ddPCR Replication Competent AAV Kit. The kits provide rapid….
GDMC Secures $21-Million Growth Capital Funding to Expand Global Genetic Medicines Design & Manufacturing Operations January 25, 2024
Genetic Design and Manufacturing Corporation (GDMC) recently announced a Series A funding of $21 million. The funding round is led...ONK Therapeutics & NAYA Biosciences Announce Research Partnership to Advance Combination Therapy of Optimally Engineered Off-the-Shelf Natural Killer Cell Therapies & FLEX-NK Bispecific Antibodies December 6, 2023
ONK Therapeutics and NAYA Biosciences Inc. announced they have entered into a research partnership to evaluate combination therapy consisting of ONK’s optimally engineered natural….
AbbVie to Acquire ImmunoGen, Including its Flagship Cancer Therapy, Expanding Solid Tumor Portfolio December 1, 2023
AbbVie Inc. and ImmunoGen, Inc. recently announced a definitive agreement under which AbbVie will acquire ImmunoGen and its flagship cancer therapy ELAHERE (mirvetuximab soravtansine-gynx), a first-in-class….
Adaptive Biotechnologies Announces New Translational Collaboration to Measure Minimal Residual Disease With clonoSEQ Assay Across BeiGene’s Lymphoid Malignancy Pipeline November 7, 2023
Adaptive Biotechnologies Corporation recently announced a multi-year, global translational collaboration with BeiGene to assess minimal residual disease (MRD) using clonoSEQ...eXmoor Completes Expansion Into Full-Service Cell & Gene Therapy CDMO Partner With Opening of GMP Facilities October 11, 2023
eXmoor pharma recently launched its new Cell and Gene Therapy Centre GMP facility, to support the simultaneous production of multiple...ALSA Ventures Launches Novel Gene Therapy Portfolio Company Axovia Therapeutics September 19, 2023
ALSA Ventures recently announced the acquisition of Axovia Therapeutics Inc and the launch of a new portfolio company Axovia Therapeutics...CELL & GENE THERAPY - Cell & Gene Therapy’s Everest – The Challenges & Opportunities That Will Shape Success September 5, 2023
Samir Acharya, PhD, Rajiv Vaidya, PhD, Laura Kerepesi, PhD, and Cyrill Kellerhals, MBA, provide their unique insights as they explore the challenges cell and gene therapy developers and manufacturers are currently facing, those they can expect to see in the future, and more critically, how to overcome them.
Valo Therapeutics & Texcell Announce Research Collaboration to Evaluate Immune Responses to PeptiCRAd-1 in Phase 1 Clinical Study June 13, 2023
Valo Therapeutics Oy recently announced a collaboration with global contract research organization, Texcell, to investigate immune responses to PeptiCRAd-1 in...Cell & Gene Therapy CDMO Targets North American Growth With Major US Acquisition May 19, 2023
uBriGene is expanding into the US market with the acquisition of a state-of-the-art GMP manufacturing facility from NASDAQ-listed company Mustang Bio, Inc. The cell & gene therapy (CGT) CDMO has an….
Siren Biotechnology Launches to Pioneer Universal AAV Immuno-Gene Therapy for Cancer May 17, 2023
Novel approach combines the promise of two transformative therapeutic technologies, AAV gene therapy and cytokine immunotherapy, into a single transformative modality….
Elevar Therapeutics Submits NDA to FDA for Combination of Rivoceranib & Camrelizumab as First-Line Treatment Option for Unresectable Hepatocellular Carcinoma May 17, 2023
Elevar Therapeutics, Inc. recently announced it submitted an NDA to the US FDA for its investigational drug rivoceranib, an oral...Arrowhead Pharmaceuticals’ Proprietary Pulmonary TRiM Platform Achieves High Levels of Target Gene Knockdown & Long Duration of Effect April 25, 2023
Interim Results from Ongoing ARO-RAGE Phase 1/2 Study Demonstrate up to 90% Serum sRAGE Reduction with Mean Maximum Reduction of 80% after Two Doses….
Catalent Commences Construction of New $20M Expansion to its Clinical Supply Facility in Schorndorf, Germany April 10, 2023
Catalent recently announced it has begun construction of a $20-million expansion project at its clinical supply facility in Schorndorf, Germany....SPECIAL FEATURE - Excipients: Their Future Could Lie in Generics April 3, 2023
Contributor Cindy H. Dubin highlights the innovative work being done by several leading companies and exemplifies the importance of excipients to the future of drug development.
BD Introduces High-Throughput Single-Cell Multiomics Platform to Expand Scope of Scientific Discovery February 3, 2023
BD (Becton, Dickinson and Company) recently announced a new instrument for single-cell multiomics analysis that will enable scientists to run...
